Acceleron Pharma has appointed Dr. Francois Nader to its board of directors. Nader is president, CEO and a member of the board of directors of NPS Pharma. Acceleron Pharma’s backers include Advanced Technology Ventures, Flagship Ventures, OrbiMed Advisors, Polaris Ventures and Venrock. Based in Cambridge, Mass., Acceleron is focused on developing novel protein therapeutics for cancer and rare diseases.Continue
Spindle Labs Inc., a developer of search technology, has raised $2.3 million in venture funding, and recently released the company’s app in iTunes. The company is backed by Polaris Ventures, Greylock Partners, Lerer Ventures, SV Angel, Atlas Ventures, Broad Beach Ventures, Project 11, Ray Ozzie and Raman Narayanan. Spindle Labs is based in Boston.Continue
eBay said Tuesday that it has agreed to buy WHI Solutions, which provides software and digital catalog solutions for auto parts distributors and retailers. Financial terms weren’t announced. Investors of Rye Brook, N.Y.-based WHI Solutions include Polaris Ventures, MidMark Capital, Viacom, Goldman Sachs and and Canopy Group. WHI’s offices will remain in New York, New Jersey […]Continue
Boston-based Ember, a provider of low-power wireless mesh networking technology has renewed its 2009 US$5 million venture debt financing. Wellington Financial arranged the financing for the original transaction which provided the company with additional working capital to accommodate its growth strategy. Venture capital backers include Polaris Ventures, GrandBanks Capital, RRE Ventures, Vulcan Capital, DFJ ePlanet […]Continue
Cambridge, Mass.-based Acceleron Pharma Inc. has raised $30 million in financing. The company said that strategic partner Celgene contributed to the round, along with “all other existing investors.” Acceleron has raised capital from Advanced Technology Ventures, Alkermes, Avalon Ventures, Bessemer Ventures, Celgene, Flagship Ventures, MPM BioEquities, OrbiMed Advisors, Polaris Ventures, QVT Financial, Sutter Hill Ventures and Venrock. The new funds will be used to expand the company’s clinical stage pipeline.Continue
Protein therapeutics company aTyr Pharma has appointed R. Alan Ezekowitz to aTyr’s Therapeutic advisory board. Physician scientist Dr. Ezekowitz has led various research and development programs at Merck. The privately-held biotech company was founded by The Scripps Research Institute Professor Paul Schimmel and is backed by life sciences investors Alta Partners, Cardinal Partners, Domain Associates […]Continue
Veronis Suhler Stevenson portfolio company Remedy Health Media, a health information and technology company, has acquired HealthCentral, a provider of online clinical and patient community resources and tools that help patients and caregivers take control of their health and improve their well-being. HealthCentral is backed by interactive media and technology investors IAC/InterActiveCorp, Polaris Ventures, Sequoia […]Continue
SustainX, the New Hampshire-based energy storage company, took on an additional $5.6 million in funding, less than two months after striking a $14.4 million funding with a group of investors. This time, General Catalyst and prior investors chipped in on its funding. Other investors include GE Energy Financial Services, a unit of GE, Cadent Energy Partners, Polaris Ventures, Rockport Capital, Small Business Innovation Research program of the National Science Foundation and the Energy Storage Program of the US Department of Energy.Continue
SustainX, which is developing technology for energy storage using compressed air, has closed on $14.4 million in financing. GE Energy Financial Services, a unit of GE, contributed to the round, as did Cadent Energy Partners and existing shareholders Polaris Ventures and Rockport Capital. New Hampshire-based SustainX previously raised $5.4 million from investors including the Small Business Innovation Research program of the National Science Foundation and the Energy Storage Program of the US Department of Energy.Continue
Acceleron Pharma, which is backed by firms including Advanced Technology Ventures, Bessemer Ventures, Polaris Ventures, Sutter Hill Ventures and Venrock, was awarded a $1.5 million grant from the Muscular Dystrophy Association. The grant will go to support clinical studies of the company’s products.Continue
Media deals got big headlines in 2010 but many transactions didn’t get big prices.
So maybe I’m still thinking about Newsweek’s sale earlier this year (the fabled magazine was sold for $1 to Sidney Harman and just recently merged with the Daily Beast). But media and marketing services may see a bump in 2011, according to survey from AdMedia Partners, a New York IB.
In November, AdMedia questioned executives from content (traditional media and digital media) and services (marketing services, digital marketing and marketing technology). Private equity was also included in the survey, AdMedia said.Continue
San Diego-based biopharmaceutical startup aTyr Pharma has just raised $23 million in Series C financing from Domain Associates, Alta Partners, Cardinal Partners and Polaris Ventures. According to the company, the money will be used to accelerate the development of its preclinical pipeline and to advance its drug candidates into clinical trials. PRESS RELEASE: aTyr Pharma, a physiocrine therapeutics company, today […]Continue
Every once in a while, a venture firm makes a head-scratching investment decision. Waltham, Mass.-based Polaris Ventures has just made a hair-calming one — for the second time. Today, the firm announced it has given Living Proof, a “technology-based” company in Cambridge that makes a line of six “frizz eliminating” sprays and creams under the […]Continue